{"ATC Code":"J01CA04","Abbreviation":"","Aliases":["Amoxycillin","26787-78-0","Amoxicillin anhydrous","Amoxicilline","p-Hydroxyampicillin","Amopenixin","Amoxicilina","Amolin","Moxal","Amoxil"],"Biological Half-Life":"The half life of amoxicillin is 61.3 minutes.","CAS":"61336-70-7","ChEBI":"CHEBI:2676","ChEMBL":"CHEMBL1082","ChemicalClasses":["amino acid"],"Chirality":"absolute","ChiralityAminoAcid":true,"Classes":["Antibiotic"],"Color/Form":"Crystals from water","Dosing Info":[],"Drug Classes":"Breast Feeding; Lactation; Milk, Human; Anti-infective Agents; Antibacterial Agents; Penicillins","Drug Indication":"Amoxicillin alone is indicated to treat susceptible bacterial infections of the ear, nose, throat, genitourinary tract, skin, skin structure, and lower respiratory tract. Amoxicillin is given with calvulanic acid to treat acute bacterial sinusitis, community acquired pneumonia, lower respiratory tract infections, acute bacterial otitis media, skin and skin structure infections, and urinary tract infections. Amoxicillin is given with omeprazole in the treatment of _Helicobacter pylori_ (_H. pylori_) infection.  Amoxicillin is used in combination with [vonoprazan] and [clarithromycin] as co-packaged triple therapy or in combination with [vonoprazan] as co-packaged dual therapy to treat _H. pylori_ infection in adults.","Drug Warnings":"Reproduction studies have been performed in mice and rats /and/ there was no evidence of harm to the fetus due to amoxicillin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, amoxicillin should be used during pregnancy only if clearly needed.","DrugClasses":[],"DurationOfAction":"","EINECS":"248-003-8","EliminationHalfLife":"61.3\u0026nbspminutes (~1\u0026nbsphour)","European Community (EC) Number":"248-003-8","FDA Pharmacological Classification":"9EM05410Q9","HMDB ID":"HMDB0015193","HeavyAtomCount":25,"Human Drugs":"Breast Feeding; Lactation; Milk, Human; Anti-infective Agents; Antibacterial Agents; Penicillins","IUPACName":"(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI":"InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1","InChIKey":"LSQZJLSUYDQPKJ-NJBDSQKTSA-N","MeSH Pharmacological Classification":"Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)","Melting Point":"194 °C","MolecularFormula":"C\u003csub\u003e16\u003c/sub\u003eH\u003csub\u003e19\u003c/sub\u003eN\u003csub\u003e3\u003c/sub\u003eO\u003csub\u003e5\u003c/sub\u003eS","MolecularWeight":"365.4 g/mol","Odor":"Penicillin-type odor","Opticalactivity":"UNSPECIFIED","Pharmacodynamics":"Amoxicillin competitively inhibit penicillin binding proteins, leading to upregulation of autolytic enzymes and inhibition of cell wall synthesis. Amoxicillin has a long duration of action as it is usually given twice daily. Amoxicillin has a wide therapeutic range as mild overdoses are not associated with significant toxicity. Patients should be counselled regarding the risk of anaphylaxis, _Clostridium difficile_ infections, and bacterial resistance.","Physical Description":"Off-white solid; [HSDB]","PrevSalts":[],"PubChemId":33613,"Record Description":["Amoxicillin is a penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-(4-hydroxyphenyl)acetamido group. It has a role as an antibacterial drug. It is a penicillin and a penicillin allergen. It is a conjugate acid of an amoxicillin(1-).","Amoxicillin is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain bacterial infections, such as infections of the ear, nose and throat; genitourinary tract; skin; and respiratory tract (including pneumonia).\u0026nbsp;","Community-acquired pneumonia, a bacterial respiratory disease, can be an opportunistic infection\u0026nbsp;(OI) of HIV.","Amoxicillin, or BRL-2333, is a penicillin G derivative first described in the literature in 1972. Amoxicillin has similar activity to [penicillin] and [ampicillin], but leads to higher serum concentrations than ampicillin.  Amoxicillin was granted FDA approval on 18 January 1974.","Amoxicillin anhydrous is a Penicillin-class Antibacterial.","Amoxicillin has been reported in Arundo donax and Apis cerana with data available.","Amoxicillin is a broad-spectrum, semisynthetic aminopenicillin antibiotic with bactericidal activity. Amoxicillin binds to and inactivates penicillin-binding protein (PBP) 1A located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This interrupts bacterial cell wall synthesis and results in the weakening of the bacterial cell wall and causes cell lysis.","Amoxicillin Anhydrous is the anhydrous form of a broad-spectrum, semisynthetic aminopenicillin antibiotic with bactericidal activity. Amoxicillin binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This interrupts bacterial cell wall synthesis and results in the weakening of the bacterial cell wall and causes cell lysis.","AMOXICILLIN is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 11 approved and 55 investigational indications.","A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.","See also: Amoxicillin-Potassium Clavulanate Combination (annotation moved to).","Amoxicillin is a penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-(4-hydroxyphenyl)acetamido group. It has a role as an antibacterial drug. It is a penicillin and a penicillin allergen. It is a conjugate acid of an amoxicillin(1-)."],"References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/Amoxicillin","Name":"Amoxicillin","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q201928","Name":"Amoxicillin","Sub":false}]},{"Name":"DrugBank","Urls":[{"Link":"https://go.drugbank.com/drugs/DB01060","Name":"Amoxicillin","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/33613","Name":"Amoxicillin","Sub":false}]},{"Name":"ChEMBL","Urls":[{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1082","Name":"Amoxicillin","Sub":false}]},{"Name":"ChEBI","Urls":[{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:2676","Name":"Amoxicillin","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=61336-70-7","Name":"Amoxicillin","Sub":false}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0015193","Name":"Amoxicillin","Sub":false}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/C06827","Name":"Amoxicillin","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/9EM05410Q9","Name":"Amoxicillin","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID3037044","Name":"Amoxicillin","Sub":false}]}],"SMILES":"CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C","Scheduling":[{"gov":"Australia","schedule":"S4 substance"},{"gov":"Canada","schedule":"prescription only substance"},{"gov":"United Kingdom","schedule":"prescription only substance"},{"gov":"United States","schedule":"prescription only substance"}],"Solubility":"10.7 [ug/mL] (The mean of the results at pH 7.4)","Stability/Shelf Life":"Stable under recommended storage conditions.","StoreUNII":["9EM05410Q9"],"StructureBase64":"<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" height="155.806mm" version="1.2" viewBox="0 0 81.112 155.806" width="81.112mm">
      
    <desc>Generated by the Chemistry Development Kit (http://github.com/cdk)</desc>
      
    <g fill="#FF0D0D" stroke="#000000" stroke-linecap="round" stroke-linejoin="round" stroke-width=".7">
            
        <rect fill="#FFFFFF" height="156.0" stroke="none" width="82.0" x=".0" y=".0"/>
            
        <g class="mol" id="mol1">
                  
            <line class="bond" id="mol1bnd1" x1="41.352" x2="33.713" y1="6.547" y2="19.735"/>
                  
            <line class="bond" id="mol1bnd2" x1="33.713" x2="47.59" y1="19.735" y2="25.941"/>
                  
            <line class="bond" id="mol1bnd3" x1="47.59" x2="46.417" y1="25.941" y2="37.28"/>
                  
            <path class="bond" d="M31.037 43.93l.145 .685l11.881 -1.119l-.353 -1.674l-.354 -1.675z" fill="#000000" id="mol1bnd4" stroke="none"/>
                  
            <line class="bond" id="mol1bnd5" x1="31.109" x2="25.411" y1="44.272" y2="34.306"/>
                  
            <line class="bond" id="mol1bnd6" x1="33.713" x2="25.927" y1="19.735" y2="28.37"/>
                  
            <line class="bond" id="mol1bnd7" x1="31.109" x2="34.26" y1="44.272" y2="59.183"/>
                  
            <line class="bond" id="mol1bnd8" x1="34.26" x2="49.171" y1="59.183" y2="56.033"/>
                  
            <line class="bond" id="mol1bnd9" x1="46.827" x2="49.171" y1="44.942" y2="56.033"/>
                  
            <g class="bond" id="mol1bnd10">
                        
                <line x1="48.814" x2="59.414" y1="54.346" y2="61.248"/>
                        
                <line x1="47.484" x2="58.084" y1="56.39" y2="63.292"/>
                      
                <line class="hi" stroke="#FF0D0D" x1="59.414" x2="54.114000000000004" y1="61.248" y2="57.797"/>
                <line class="hi" stroke="#FF0D0D" x1="58.084" x2="52.784000000000006" y1="63.292" y2="59.841"/>
            </g>
                  
            <path class="bond" d="M34.553 59.374l-.587 -.382l-7.007 8.464l1.344 .875l1.344 .876z" fill="#000000" id="mol1bnd11" stroke="none"/>
                  
            <line class="bond" id="mol1bnd12" x1="27.822" x2="32.846" y1="75.653" y2="85.542"/>
                  
            <g class="bond" id="mol1bnd13">
                        
                <line x1="32.208" x2="44.472" y1="84.287" y2="84.945"/>
                        
                <line x1="32.078" x2="44.341" y1="86.722" y2="87.379"/>
                      
                <line class="hi" stroke="#FF0D0D" x1="44.472" x2="38.34" y1="84.945" y2="84.616"/>
                <line class="hi" stroke="#FF0D0D" x1="44.341" x2="38.209500000000006" y1="87.379" y2="87.0505"/>
            </g>
                  
            <line class="bond" id="mol1bnd14" x1="32.846" x2="24.53" y1="85.542" y2="98.313"/>
                  
            <line class="bond" id="mol1bnd15" x1="24.53" x2="31.432" y1="98.313" y2="111.9"/>
                  
            <g class="bond" id="mol1bnd16">
                        
                <line x1="46.654" x2="31.432" y1="112.642" y2="111.9"/>
                        
                <line x1="45.145" x2="32.704" y1="115.01" y2="114.404"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd17" x1="46.654" x2="53.637" y1="112.642" y2="125.9"/>
                  
            <g class="bond" id="mol1bnd18">
                        
                <line x1="45.359" x2="53.637" y1="139.23" y2="125.9"/>
                        
                <line x1="44.045" x2="50.829" y1="136.724" y2="125.801"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd19" x1="45.359" x2="30.137" y1="139.23" y2="138.488"/>
                  
            <g class="bond" id="mol1bnd20">
                        
                <line x1="23.193" x2="30.137" y1="124.418" y2="138.488"/>
                        
                <line x1="25.998" x2="31.689" y1="124.591" y2="136.122"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd21" x1="31.432" x2="23.193" y1="111.9" y2="124.418"/>
                  
            <line class="bond" id="mol1bnd22" x1="45.359" x2="50.607" y1="139.23" y2="149.231"/>
                  
            <path class="bond" d="M24.511 98.663l.038 -.699l-11.806 -2.002l-.092 1.714l-.092 1.714z" fill="#000000" id="mol1bnd23" stroke="none"/>
                  
            <g class="bond" id="mol1bnd24">
                        
                <line x1="47.415" x2="47.765" y1="25.638" y2="26.244"/>
                        
                <line x1="49.469" x2="50.11" y1="24.115" y2="25.227"/>
                        
                <line x1="51.522" x2="52.456" y1="22.593" y2="24.21"/>
                        
                <line x1="53.576" x2="54.801" y1="21.07" y2="23.192"/>
                        
                <line x1="55.63" x2="57.147" y1="19.548" y2="22.175"/>
                        
                <line x1="57.684" x2="59.492" y1="18.025" y2="21.157"/>
                        
                <line x1="59.738" x2="61.838" y1="16.502" y2="20.14"/>
                      
            </g>
                  
            <g class="bond" id="mol1bnd25">
                        
                <line x1="60.788" x2="60.788" y1="18.321" y2="7.002"/>
                        
                <line x1="63.226" x2="63.226" y1="16.913" y2="7.002"/>
                      
                <line class="hi" stroke="#FF0D0D" x1="60.788" x2="60.788" y1="7.001999999999999" y2="12.6615"/>
                <line class="hi" stroke="#FF0D0D" x1="63.226" x2="63.226" y1="7.001999999999999" y2="11.9575"/>
            </g>
                  
            <line class="bond" id="mol1bnd26" x1="60.788" x2="70.702" y1="18.321" y2="24.045"/>
                  
            <line class="bond" id="mol1bnd27" x1="33.713" x2="21.394" y1="19.735" y2="10.764"/>
                  
            <path class="atom" d="M47.961 43.572h-.72l-2.62 -4.066h-.029q.011 .238 .029 .595q.024 .357 .024 .733v2.738h-.565v-4.899h.714l2.607 4.054h.03q-.006 -.108 -.018 -.328q-.012 -.22 -.024 -.476q-.005 -.262 -.005 -.482v-2.768h.577v4.899z" fill="#3050F8" id="mol1atm4" stroke="none"/>
                  
            <path class="atom" d="M25.078 32.161q.0 .649 -.476 1.018q-.47 .363 -1.268 .363q-.417 -.0 -.768 -.066q-.345 -.059 -.577 -.172v-.59q.244 .113 .607 .203q.369 .089 .762 .089q.548 -.0 .827 -.214q.28 -.215 .28 -.578q.0 -.238 -.107 -.399q-.101 -.166 -.351 -.309q-.25 -.143 -.697 -.298q-.625 -.226 -.946 -.554q-.316 -.333 -.316 -.898q.0 -.393 .197 -.667q.202 -.28 .553 -.429q.357 -.155 .816 -.155q.405 .0 .738 .078q.339 .071 .613 .196l-.196 .53q-.25 -.113 -.548 -.184q-.298 -.078 -.625 -.078q-.458 .0 -.691 .197q-.232 .196 -.232 .518q.0 .244 .101 .41q.108 .167 .34 .298q.232 .125 .631 .28q.428 .155 .726 .339q.298 .179 .453 .435q.154 .25 .154 .637z" fill="#C6C62C" id="mol1atm6" stroke="none"/>
                  
            <path class="atom" d="M64.201 64.346q-.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.245 -.572 -.245 -1.334q.0 -.75 .245 -1.309q.25 -.566 .756 -.882q.506 -.315 1.274 -.315q.732 -.0 1.232 .315q.5 .31 .756 .876q.256 .565 .256 1.327zM60.337 64.346q.0 .923 .387 1.459q.393 .529 1.221 .529q.839 .0 1.22 -.529q.387 -.536 .387 -1.459q-.0 -.929 -.387 -1.452q-.381 -.524 -1.208 -.524q-.834 -.0 -1.227 .524q-.393 .523 -.393 1.452z" id="mol1atm9" stroke="none"/>
                  
            <g class="atom" id="mol1atm10">
                        
                <path d="M27.884 74.404h-.72l-2.619 -4.066h-.03q.012 .238 .03 .596q.024 .357 .024 .732v2.738h-.566v-4.899h.714l2.608 4.054h.03q-.006 -.107 -.018 -.328q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.768h.577v4.899z" fill="#3050F8" stroke="none"/>
                        
                <path d="M23.441 74.404h-.619v-2.286h-2.512v2.286h-.613v-4.899h.613v2.071h2.512v-2.071h.619v4.899z" fill="#3050F8" stroke="none"/>
                      
            </g>
                  
            <path class="atom" d="M50.323 86.355q.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q-.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.732 .0 1.232 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM46.46 86.355q-.0 .923 .387 1.459q.392 .53 1.22 .53q.839 -.0 1.22 -.53q.387 -.536 .387 -1.459q.0 -.928 -.387 -1.452q-.381 -.524 -1.208 -.524q-.834 -.0 -1.227 .524q-.392 .524 -.392 1.452z" id="mol1atm12" stroke="none"/>
                  
            <g class="atom" id="mol1atm20">
                        
                <path d="M54.699 152.722q-.0 .756 -.256 1.327q-.256 .566 -.756 .882q-.5 .315 -1.245 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.888q-.244 -.571 -.244 -1.333q.0 -.75 .244 -1.31q.25 -.565 .756 -.881q.506 -.315 1.274 -.315q.733 -.0 1.233 .315q.5 .31 .756 .875q.256 .566 .256 1.328zM50.835 152.722q.0 .923 .387 1.458q.393 .53 1.22 .53q.84 .0 1.221 -.53q.387 -.535 .387 -1.458q-.0 -.929 -.387 -1.453q-.381 -.524 -1.209 -.524q-.833 .0 -1.226 .524q-.393 .524 -.393 1.453z" stroke="none"/>
                        
                <path d="M59.005 155.175h-.619v-2.286h-2.512v2.286h-.614v-4.9h.614v2.072h2.512v-2.072h.619v4.9z" stroke="none"/>
                      
            </g>
                  
            <g class="atom" id="mol1atm21">
                        
                <path d="M11.252 99.946h-.72l-2.619 -4.066h-.03q.012 .239 .03 .596q.024 .357 .024 .732v2.738h-.566v-4.899h.714l2.608 4.054h.03q-.006 -.107 -.018 -.327q-.012 -.221 -.024 -.477q-.006 -.261 -.006 -.482v-2.768h.577v4.899z" fill="#3050F8" stroke="none"/>
                        
                <path d="M4.305 99.946h-.62v-2.286h-2.512v2.286h-.613v-4.899h.613v2.072h2.512v-2.072h.62v4.899z" fill="#3050F8" stroke="none"/>
                        
                <path d="M6.809 101.436h-1.943v-.3l.772 -.779q.221 -.221 .371 -.393q.154 -.175 .232 -.339q.079 -.168 .079 -.364q-.0 -.243 -.147 -.368q-.142 -.129 -.371 -.129q-.214 .0 -.379 .075q-.16 .075 -.328 .207l-.193 -.243q.171 -.146 .393 -.246q.225 -.1 .507 -.1q.411 -.0 .65 .207q.239 .207 .239 .575q.0 .229 -.096 .432q-.093 .2 -.264 .397q-.168 .196 -.393 .418l-.615 .603v.018h1.486v.329z" fill="#3050F8" stroke="none"/>
                      
            </g>
                  
            <path class="atom" d="M64.266 3.078q.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q-.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.732 .0 1.232 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM60.403 3.078q-.0 .923 .387 1.459q.393 .53 1.22 .53q.839 -.0 1.22 -.53q.387 -.536 .387 -1.459q.0 -.929 -.387 -1.452q-.381 -.524 -1.208 -.524q-.833 -.0 -1.226 .524q-.393 .523 -.393 1.452z" id="mol1atm23" stroke="none"/>
                  
            <g class="atom" id="mol1atm24">
                        
                <path d="M76.245 25.938q.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q-.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.732 .0 1.232 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM72.382 25.938q-.0 .923 .387 1.459q.393 .53 1.22 .53q.839 -.0 1.22 -.53q.387 -.536 .387 -1.459q.0 -.929 -.387 -1.452q-.381 -.524 -1.208 -.524q-.833 -.0 -1.226 .524q-.393 .523 -.393 1.452z" stroke="none"/>
                        
                <path d="M80.552 28.391h-.62v-2.286h-2.512v2.286h-.613v-4.9h.613v2.072h2.512v-2.072h.62v4.9z" stroke="none"/>
                      
            </g>
                
            <line class="hi" id="mol1bnd3" stroke="#3050F8" x1="46.417" x2="47.0035" y1="37.28" y2="31.610500000000002"/>
            <line class="hi" id="mol1bnd5" stroke="#C6C62C" x1="25.411" x2="28.26" y1="34.306" y2="39.289"/>
            <line class="hi" id="mol1bnd6" stroke="#C6C62C" x1="25.927" x2="29.82" y1="28.37" y2="24.052500000000002"/>
            <line class="hi" id="mol1bnd9" stroke="#3050F8" x1="46.827" x2="47.998999999999995" y1="44.942" y2="50.4875"/>
            <line class="hi" id="mol1bnd12" stroke="#3050F8" x1="27.822" x2="30.333999999999996" y1="75.653" y2="80.5975"/>
            <line class="hi" id="mol1bnd12" stroke="#3050F8" x1="27.822" x2="30.333999999999996" y1="75.653" y2="80.5975"/>
            <line class="hi" id="mol1bnd22" stroke="#FF0D0D" x1="50.607" x2="47.983000000000004" y1="149.231" y2="144.2305"/>
            <line class="hi" id="mol1bnd26" stroke="#FF0D0D" x1="70.702" x2="65.745" y1="24.045" y2="21.183"/>
        </g>
          
    </g>
    
</svg>
","Taste":"Bitter tasting","Therapeutic Uses":"Anti-Bacterial Agents","Title":"Amoxicillin","UNII":"9EM05410Q9","Wikidata":"Q201928","Wikipedia":"Amoxicillin","XLogP":-2}